Literature DB >> 32284133

Bioactive-guided structural optimization of 1,2,3-triazole phenylhydrazones as potential fungicides against Fusarium graminearum.

Yiliang Chen1, Kaicheng Yao1, Kaiyan Wang1, Cheng Xiao1, Ke Li1, Babar Khan1, Shuangshuang Zhao1, Wei Yan2, Yonghao Ye3.   

Abstract

The phytopathogenic fungus Fusarium graminearum is the major causal agent of fusarium head blight (FHB), which is one of the most serious diseases in wheat. Based on our previous work, the 1,2,3-triazole phenylhydrazone scaffold was further optimized at three modification sites to improve its antifungal activity against F. graminearum. The optimization yielded compound 8d was discovered to be a potent fungicidal agent with an EC50 value of 0.28 μg/mL against F. graminearum, which is 3.6 times lower than previously reported. In addition, 8d also exhibited good inhibitory activities against Rhizoctonia solani and Sclerotinia sclerotiorum with EC50 values of 0.86 and 1.66 μg/mL, respectively. In vivo testing demonstrated that 8d could effectively suppress the disease development of FHB at 200 μg/mL with a protection efficacy of 80.6%. Scanning electron micrographs and transmission electron micrographs showed that the external morphology and internal contents of F. graminearum hyphae were abnormal after 24 h of 8d treatment. Therefore, compound 8d was a promising fungicide candidate for further development.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  1,2,3-triazole; Antifungal activity; Fusarium graminearum; Phenylhydrazone

Year:  2019        PMID: 32284133     DOI: 10.1016/j.pestbp.2019.12.004

Source DB:  PubMed          Journal:  Pestic Biochem Physiol        ISSN: 0048-3575            Impact factor:   3.963


  1 in total

1.  1,4-Disubstituted-1,2,3-Triazole Compounds Induce Ultrastructural Alterations in Leishmania amazonensis Promastigote: An in Vitro Antileishmanial and in Silico Pharmacokinetic Study.

Authors:  Fernando Almeida-Souza; Verônica Diniz da Silva; Gabriel Xavier Silva; Noemi Nosomi Taniwaki; Daiana de Jesus Hardoim; Camilla Djenne Buarque; Ana Lucia Abreu-Silva; Kátia da Silva Calabrese
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.